Brain Cannabinoid CB2 Receptor in SchizophreniaHiroki Ishiguro, Tadao Arinami, Yoshimi Suzuki et al.|Biological Psychiatry|2009Cited by 184
Supportive Evidence for Reduced Expression of GNB1L in SchizophreniaHiroki Ishiguro, Tadao Arinami, Minori Koga et al.|Schizophrenia Bulletin|2008Cited by 31